Key result
Ongoing observational study assesses cardiorenal anemia syndrome prevalence and outcomes in Tanzanian HF patients.
Why the study?
Cardiorenal anemia syndrome (CRAS) is common in heart failure and linked to poor outcomes, but published data remain scarce despite rising heart failure cases in developing countries.
Observational (n=300)
No
This protocol describes a planned prospective observational study to assess the prevalence, clinical correlates, and 6-month outcomes of cardiorenal anemia syndrome in Tanzanian patients with heart failure.
No immediate practice change from this protocol; leaves open prevalence and outcomes of cardiorenal anemia syndrome in sub-Saharan HF.
BACKGROUND: Cardiorenal anemia syndrome (CRAS) is a common complication among patients with heart failure and is associated with poor clinical outcomes. However, there is a paucity of published data concerning CRAS, despite of significant increase in heart failure patients attending medical services in developing countries. This study aims to assess the prevalence, clinical correlates, and outcomes of CRAS among patients with heart failure attending the Benjamin Mkapa Hospital in Dodoma, Tanzania. METHODOLOGY: A prospective observational study is ongoing at the Benjamin Mkapa Hospital in Dodoma, Tanzania. Currently, 92 patients have been recruited into this study and process is not yet completed. The socio-demographic data, clinical correlates, and prevalence of CRAS will be determined at baseline meanwhile, the outcomes of CRAS will be determined during a follow-up period of six months from the date of enrollment. CRAS is the primary outcome of the study. Data will be categorized into CRAS and non-CRAS during statistical analysis. Mean and standard deviation will be used for normally distributed continuous variables while median and interquartile range will be used for skewed data. Frequencies and percentages will summarize categorical variables. Clinical correlates and outcomes of CRAS will be analyzed and compared by using univariate and multivariate logistic regression and Cox proportional hazards models. A two-tailed p-value of less than 0.05 will indicate statistical significance.
No takes yet. Share an insight, caveat, or question.
Edwin et al. (2024) conducted an observational in Heart failure (n=300). Cardiorenal anemia syndrome (CRAS) vs. Non-CRAS was evaluated on Cardiorenal anemia syndrome (CRAS) prevalence. Cardiorenal anemia syndrome prevalence, clinical correlates, and outcomes will be assessed in an ongoing prospective observational study of 300 patients with heart failure in Tanzania.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: